- Disease: Respiratory syncytial virus infection
- Study type: Observational Cohort Study, Prevention
- Study type descriptors: Retrospective, Multicentre
- Objective: To evaluate treatment adherence rates among infants enrolled in the RSV immunoprophylaxis program using Palivizumab
- Number of participants enrolled: 1903
- Study enrolling from to
- Study includes follow-up for 5 months
Study Data
- Fragile population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Pharmacological intervention
- Monoclonal antibodies
- Palivizumab
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to